SynthesisBMC cancer2026

Efficacy and safety of CD30-targeted chimeric antigen receptor T-cell therapy for lymphoma: a meta-analysis.

Jixiang Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.